日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neutropenia and infectious events during off-label treatment with venetoclax in children with malignant disease: a pharmacovigilance analysis of FDA adverse event reporting system reports

儿童恶性肿瘤患者接受维奈托克超适应症治疗期间发生中性粒细胞减少症和感染事件:基于FDA不良事件报告系统的药物警戒分析

Muratore, Edoardo; Giunchi, Valentina; Fusaroli, Michele; Baccelli, Francesco; Gottardi, Francesca; Poluzzi, Elisabetta; Masetti, Riccardo; Raschi, Emanuel

Enhancing Medication Adherence in Older Adults: A Systematic Review of Evidence-Based Strategies

提高老年人用药依从性:循证策略的系统评价

Scotti, Stefano; Pasina, Luca; Lunghi, Carlotta; Raschi, Emanuel; Rossi, Andrea; Olmastroni, Elena; Salluzzo, Marco; Mucherino, Sara; Orlando, Valentina; Nobili, Alessandro; Menditto, Enrica; Poluzzi, Elisabetta; Casula, Manuela

Safety of Hydroxychloroquine: What a Dermatologist Should Know

羟氯喹的安全性:皮肤科医生应该了解什么

Rapparini, Luca; Cedirian, Stephano; La Placa, Michelangelo; Piraccini, Bianca Maria; Raschi, Emanuel; Starace, Michela

Long-term surveillance of the anti-amyloid monoclonal antibody lecanemab: rights and duties of pharmacovigilance

对抗淀粉样蛋白单克隆抗体lecanemab的长期监测:药物警戒的权利和义务

Donati, Monia; Boccia, Angela; De Ponti, Fabrizio; Poluzzi, Elisabetta; Raschi, Emanuel

Towards personalized therapy for atrial fibrillation: the rhythmic climbing of dronedarone

迈向房颤个体化治疗:决奈达隆的节律性攀升

Carelli, Maria; Raschi, Emanuel; Diemberger, Igor

Gastrointestinal Perforations Associated With JAK Inhibitors: A Disproportionality Analysis of the FDA Adverse Event Reporting System

JAK抑制剂相关胃肠道穿孔:FDA不良事件报告系统比例失衡分析

Goldman, Adam; Raschi, Emanuel; Druyan, Amit; Sharif, Kassem; Lahat, Adi; Ben-Zvi, Ilan; Ben-Horin, Shomron

The interface of depression and diabetes: treatment considerations

抑郁症与糖尿病的交汇:治疗考量

Fanelli, Giuseppe; Raschi, Emanuel; Hafez, Gaye; Matura, Silke; Schiweck, Carmen; Poluzzi, Elisabetta; Lunghi, Carlotta

β2GPI-targeted polymeric nanoparticles form a protective layer to prevent vascular thrombosis in an anti-phospholipid syndrome model

β2GPI靶向聚合物纳米颗粒在抗磷脂综合征模型中形成保护层,从而预防血管血栓形成。

Durigutto, Paolo; Grimaldi, Maria Cristina; Bozzer, Sara; Raschi, Elena; Meroni, Pierluigi; Tedesco, Francesco; Macor, Paolo

Ivabradine, atrial fibrillation and stroke: a combined meta-analysis and FAERS disproportionality analysis

伊伐布雷定、房颤和卒中:一项综合荟萃分析和FAERS不成比例性分析

Spadotto, Alberto; Fusaroli, Michele; Carelli, Maria; Nardi, Elena; Amadori, Martina; Massaro, Giulia; De Angelis, Veronica; Gatti, Milo; Ciubine, Valerio; Raschi, Emanuel; Poluzzi, Elisabetta; Diemberger, Igor

Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons

GLP-1受体激动剂的获益风险评估:对皮肤科医生和整形外科医生的启示

Cedirian, Stephano; Donati, Monia; Rapparini, Luca; Pampaloni, Francesca; La Placa, Michelangelo; Sgarzani, Rossella; Negosanti, Luca; Raschi, Emanuel; Starace, Michela